Skip to main content
logo
Syndax Pharmaceuticals, Inc. (SNDX)
NASDAQ: SNDX · Real-Time Price · USD
20.51
+0.41 (2.04%)
Sep 2, 2026, 10:06 AM EDT - Market open

Syndax Pharmaceuticals Revenue

Syndax Pharmaceuticals had revenue of $72.79M in the quarter ending June 30, 2026, with 91.76% growth. This brings the company's revenue in the last twelve months to $252.25M, up 222.65% year-over-year. In the year 2025, Syndax Pharmaceuticals had annual revenue of $172.35M with 627.84% growth.

Revenue (ttm)
$252.25M
Revenue Growth
+222.65%
P/S Ratio
7.12
Revenue / Employee
$846,480
Employees
298
Market Cap
1.83B

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025172.35M148.67M627.84%
Dec 31, 202423.68M--
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021139.71M138.19M9,109.56%
Dec 31, 20201.52M--
Dec 31, 20191.52M--
Dec 31, 20181.52M-591.00K-28.04%
Dec 31, 20172.11M888.00K72.79%
Dec 31, 20161.22M593.00K94.58%
Dec 31, 2015627.00K--
Dec 31, 2014---
Dec 31, 2013---
Dec 31, 2012---
Dec 31, 2011---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Fortrea Holdings2.68B
Vir Biotechnology303.23M
AnaptysBio232.39M
Apnimed120.15M
Septerna98.88M
Ascentage Pharma Group International94.61M
Intellia Therapeutics59.51M
Recursion Pharmaceuticals54.86M
Revenue Rankings

SNDX News

More News